APA-Zitierstil (7. Ausg.)

Bröckelmann, P. J., Goergen, H., Keller, U., Meißner, J., Ordemann, R., Halbsguth, T. V., . . . Engert, A. (2020). Efficacy of Nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: The randomized phase 2 German Hodgkin Study Group NIVAHL trial. JAMA oncology, 6(6), . https://doi.org/10.1001/jamaoncol.2020.0750

Chicago-Zitierstil (17. Ausg.)

Bröckelmann, Paul Jan, et al. "Efficacy of Nivolumab and AVD in Early-stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial." JAMA Oncology 6, no. 6 (2020). https://doi.org/10.1001/jamaoncol.2020.0750.

MLA-Zitierstil (9. Ausg.)

Bröckelmann, Paul Jan, et al. "Efficacy of Nivolumab and AVD in Early-stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial." JAMA Oncology, vol. 6, no. 6, 2020, https://doi.org/10.1001/jamaoncol.2020.0750.